Crashpad is a podcast where we interview founders and employees of startups that raised venture capital funding but ended up failing. We explore the origin of the company, the fundraising process (when applicable), and what eventually leads to the company’s demise. Our goal is to educate our listeners about the difficulties of creating a successful startup and how raising money does not guarantee success.
Crashpad is brought to you by Maanav Sunderaraman and Vivek James.
Vivek is currently a student at the University of Pennsylvania and has previously worked for YCombinator and AI startups.
Maanav is currently a student at McGill University and is part of the investment team at Front Row Ventures. He has previously worked for AI and Fintech startups in Montreal.
This week we speak to Gary Coventry, former Head of Product Development and Innovation at MELA Sciences, a biotech firm centered around melanoma detection that received millions in funding and even IPOed. Unfortunately, they eventually fell into a downward spiral and was forced to rebrand. Listen to the story of the downward spiral of MELA in this episode.
